✦ LIBER ✦

The effect of systemically administered recombinant human nerve growth factor in healthy human subjects

✍ Scribed by Dr. Brent G. Petty; David R. Cornblath; Bruce T. Adornato; Vinay Chaudhry; Charles Flexner; Matthew Wachsman; Dominick Sinicropi; Louis E. Burton; Stephen J. Peroutka

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 325 KB
Volume: 36
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410360221

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of zinc binding and precipitation

Effect of zinc binding and precipitation on structures of recombinant human growth hormone and nerve growth factor

✍ Tzung-Horng Yang; Jeffrey L. Cleland; Xanthe Lam; Jeffrey D. Meyer; Latoya S. Jo 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 254 KB 👁 2 views

Metal-induced precipitation of protein therapeutics is being used and further developed as a processing step in protein formulation and may have utility in protein purification and bulk storage. In such processes, it is imperative that native protein structure is maintained and the metal complexatio

Does recombinant human insulin-like grow

Does recombinant human insulin-like growth factor-1 have a role in the treatment of diabetes?

✍ Dunger, D.B; Acerini, C.L. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB 👁 1 views

The structure of IGF-I is similar to that of insulin, having 43 % sequence homology with human proinsulin. Both peptides can induce metabolic and mitogenic effects through their own specific receptors, which also share many structural and functional similarities. Primarily involved in the regulation

Somatic characteristics and cardiovascul

Somatic characteristics and cardiovascular risk factors in growth hormone deficiency: A randomized, double-blind, placebo-controlled study of the effect of treatment with recombinant human growth hormone

✍ W. Bell; J.S. Davies; W.D. Evans; M.F. Scanlon; R. Mullen 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

Recombinant human anti–transforming grow

Recombinant human anti–transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192

✍ Christopher P. Denton; Peter A. Merkel; Daniel E. Furst; Dinesh Khanna; Paul Eme 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 1 views

## Abstract ## Objective To evaluate CAT‐192, a recombinant human antibody that neutralizes transforming growth factor β1 (TGFβ1), in the treatment of early‐stage diffuse cutaneous systemic sclerosis (dcSSc). ## Methods Patients with SSc duration of <18 months were randomly assigned to the place

Small interfering RNA inhibition of SPAR

Small interfering RNA inhibition of SPARC attenuates the profibrotic effect of transforming growth factor β1 in cultured normal human fibroblasts

✍ Xiaodong Zhou; Filemon K. Tan; Xinjian Guo; Debra Wallis; Dianna M. Milewicz; Sa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB 👁 2 views

Transforming growth factor-β1 enhances t

Transforming growth factor-β1 enhances the lethal effects of DNA-damaging agents in a human lung-cancer cell line

✍ Stéphane Raynal; Silvano Nocentini; Alain Croisy; David A. Lawrence; Pierre Jull 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 108 KB 👁 1 views

In memoriam to the late Philippe Vigier , Emeritus Head of the Department of Retrovirology, Institut Curie. In wartime he fought for the freedom of his country, in peacetime for the elucidation of cancer.